Perrigo Paying $309M To Settle $1.9Bn Irish Tax Assessment From Elan Merger

OTC private label/store brand giant announces Irish authorities allow it to pay $308.7m to settle a $1.9bn assessment for back taxes ordered in 2018 linked to Rx ingredient royalty rights it gained in its 2103 merger with Elan.

• Source: Alamy

There’s a reason Perrigo Company PLC’s share price increased nearly 12% in after-hours trading on 29 September – nearly 309 million reasons, actually.

The OTC private label and store brand giant announced after the markets closed that Irish authorities agreed to let it pay €266.1m ($308.7m) to settle a €1.6bn ($1

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business